Pharma giant to acquire Cambridge's Momenta for $6.5B

Cambridge drugmaker Momenta Pharmaceuticals is set to be acquired by one of the largest pharmaceutical companies in the U.S.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.